This week, OpenAI announced a loosened partnership with Microsoft and an aggressive new strategy to secure computing power. We unpack what these updates signal about OpenAI’s business strategy and whether the company can scale while balancing a trial against Elon Musk and investor concerns over missed financial targets. Then, the A.I. researcher Dr. Adam Rodman, of Harvard Medical School, returns to tell us about the most significant ways A.I. is changing how doctors treat patients. And finally, can an LLM trained only on very old texts predict the future? We’re talking with one of the creators of the chatbot talkie. Adam Rodman, internal medicine physician at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School. David Duvenaud, associate professor at the University of Toronto, former team lead at Anthropic and co-creator of talkie. Additional Reading: Microsoft and OpenAI Loosen Their Partnership Elon Musk and Sam Altman’s Epic Fight Heads to Court OpenAI Misses Key Revenue, User Targets in High-Stakes Sprint Toward IPO Take It From a Doctor: It’s OK if Your Medical Advice Comes From A.I. We want to hear from you. Email us at hardfork@nytimes.com. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company.